WallStreetZenWallStreetZen

NASDAQ: HOTH
Hoth Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for HOTH

Based on 2 analysts offering 12 month price targets for Hoth Therapeutics Inc.
Min Forecast
$4.00+238.98%
Avg Forecast
$5.50+366.1%
Max Forecast
$7.00+493.22%

Should I buy or sell HOTH stock?

Based on 2 analysts offering ratings for Hoth Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HOTH stock forecasts and price targets.

HOTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-05
lockedlocked$00.00+00.00%2024-04-02

1 of 1

HOTH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HOTH$1.18$5.50+366.10%Strong Buy
GTBP$3.80N/AN/A
KA$0.49$8.00+1,546.09%Buy
OGEN$1.13N/AN/A
SNPX$4.66N/AN/A

Hoth Therapeutics Stock Forecast FAQ

Is Hoth Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: HOTH) stock is to Strong Buy HOTH stock.

Out of 2 analysts, 1 (50%) are recommending HOTH as a Strong Buy, 1 (50%) are recommending HOTH as a Buy, 0 (0%) are recommending HOTH as a Hold, 0 (0%) are recommending HOTH as a Sell, and 0 (0%) are recommending HOTH as a Strong Sell.

If you're new to stock investing, here's how to buy Hoth Therapeutics stock.

What is HOTH's Price Target?

According to 2 Wall Street analysts that have issued a 1 year HOTH price target, the average HOTH price target is $5.50, with the highest HOTH stock price forecast at $7.00 and the lowest HOTH stock price forecast at $4.00.

On average, Wall Street analysts predict that Hoth Therapeutics's share price could reach $5.50 by Apr 5, 2025. The average Hoth Therapeutics stock price prediction forecasts a potential upside of 366.1% from the current HOTH share price of $1.18.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.